Hotlines ESC 2012

Hot Line I: Late Breaking Trials on Prevention to Heart Failure

26 Aug 2012, 11:00-12:30
Chairperson: G F Tomaselli (Baltimore, US), M Komajda (Paris, FR)

11:00: PURE: Patterns of risk factor prevalence for CVD globally by urbanization, gender, and economic status of countries and individuals: The Prospective Urban Rural Epidemiologic (PURE) Study of 153,996 people from 628 communities in 17 countries
S Yusuf (Hamilton, CA), Discussant: D A Wood (London, GB)

11:15: DeFACTO: Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography
 J Min (Los Angeles, US), Discussant: J-P Bassand (Besancon Cedex, FR)

11:30: ALTITUDE: ALiskiren Trial In Type 2 Diabetes Using cardio-renal Endpoints
HH Parving (Copenhagen, DK), Discussant: A A Voors (Groningen, NL)

11:45: TRILOGY-ACS: Prasugrel versus clopidodrel for patients with Unstable Angina/NSTEMI who are medically managed without revascularization
MT Roe (Durham, US), Discussant: R De Caterina (Chieti, IT)

12:00: PARAMOUNT: Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Patients with Heart Failure and Preserved Ejection Fraction: Primary Results from the PARAMOUNT Study
S Solomon (Boston, US), Discussant: P Ponikowski (Wroclaw, PL)

12:15: Aldo-DHF: Aldosterone Receptor Blockade in Diastolic Heart Failure
B Pieske (Graz, AT), Discussant: J G F Cleland (Kingston Upon Hull, GB)

Hot Line II: Late Breaking Trials on Interventions

27 Aug 2012, 11:00-12:30
Chairperson: M Boehm (Homburg/Saar, DE), F J Pinto (Lisbon, PT)

11:00: IABP-SHOCK II: Randomized comparison of intraaortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated by cardiogenic shock
H Thiele (Leipzig, DE), Discussant: U C Hoppe (Salzburg, AT)

11:15: PROTECT: Primary Results from PROTECT: thePatient Related Outcomes with Endeavor versus Cypher Stenting Trial
W Wijns (Aalst, BE), Discussant:  S Windecker (Bern, CH)

11:30: GARY: German Aortic Valve RegistrY – in hospital outcome
C W Hamm (Bad Nauheim, DE), Discussant: O Wendler (London, GB)

11:45: ACCESS-EUROPE – An Observational Study of the MitraClip® System in Europe
W Schillinger (Gottingen, DE), Discussant: S Ray (Manchester, GB)

12:00: FAST-MI programme: Decrease in early mortality in STEMI is related to changing patient profile and behavior, as well as improved organization of care: Data from 4 French nationwide surveys over 15 years.
N Danchin (Paris, FR), Discussant: F Crea (Roma, IT)

12:15: GRACE: Effects of Insulin Glargin and of Polyunsaturated Fatty Acids on Carotid Intima Media Thickness in High-Risk Diabetes
 E Lonn (Hamilton, CA), Discussant:  J E Deanfield (London, GB)

Hot Line III: Late Breaking Trials on Arrhythmias and CAD

28 Aug 2012, 11:00-12:30
Chairperson: D Holmes (Rochester, US), K A A Fox (Edinburgh, GB)

11:00: PRAGUE-12: Randomized open multicenter study comparing cardiac surgery with MAZE versus cardiac surgery without MAZE in patients with coronary and/or valvular heart disease and with atrial fibrillation
P Widimsky (Prague, CZ), Discussant: R Cappato (San Donato, IT)

11:15: WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI).
 W J M Dewilde (Maaseik, BE). Discussant:  M Valgimigli (Ferrara, IT)

11:30: AFib Ablation Pilot: ESC-EURObservational Research Programme: 1-year follow-up of the Atrial Fibrillation Ablation Conducted by the European Heart Rhythm Association
 E Arbelo (Las Palmas De Gran Canaria, ES), Discussant: C Leclercq (Rennes, FR)

11:45: The Great East Japan Earthquake Disaster and Cardiovascular Diseases
H Shimokawa (Sendai, JP), Discussant: G Steinbeck (Munich, DE)

12:00: CORE320: Diagnostic Performance of Combined Noninvasive Coronary Angiography and Myocardial Perfusion Imaging Using 320-row Detector Computed Tomography : The CORE320 Multicenter, Multinational Study
   J A C Lima (Baltimore, US), Discussant: G Maurer (Vienna, AT)

12:15: FAME II: Fractional Flow Reserve-Guided Percutaneous Coronary Intervention plus Optimal Medical Treatment versus Optimal Medical Treatment Alone in Patients with Stable Coronary Artery Disease
B De Bruyne (Aalst, BE), Discussant: F Van de Werf (Leuven, BE)